This content is from: Features

Deriving value for insurance companies

Derivatives have traditionally been viewed as forbidden territory to insurance companies. But is this always true? Maria Ross and Charlotte Davies of Norton Rose, London, ask if the two can be reconciled

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial